Chavez-Arias, T.; Manrique-Sam, C.; Ita-Balta, Y.; Montánchez-Carazas, E.; Murillo Carrasco, A.G.; Farfán-Delgado, M.
Population-Specific Pharmacogenomic Profiling of NAT2, CYP2E1, and SLCO1B1 in Tuberculosis Patients from Southern Peru: A Feasibility Pilot Study. J. Pers. Med. 2026, 16, 184.
https://doi.org/10.3390/jpm16040184
AMA Style
Chavez-Arias T, Manrique-Sam C, Ita-Balta Y, Montánchez-Carazas E, Murillo Carrasco AG, Farfán-Delgado M.
Population-Specific Pharmacogenomic Profiling of NAT2, CYP2E1, and SLCO1B1 in Tuberculosis Patients from Southern Peru: A Feasibility Pilot Study. Journal of Personalized Medicine. 2026; 16(4):184.
https://doi.org/10.3390/jpm16040184
Chicago/Turabian Style
Chavez-Arias, Tatiana, Cecilia Manrique-Sam, Yuma Ita-Balta, Edgar Montánchez-Carazas, Alexis Germán Murillo Carrasco, and Miguel Farfán-Delgado.
2026. "Population-Specific Pharmacogenomic Profiling of NAT2, CYP2E1, and SLCO1B1 in Tuberculosis Patients from Southern Peru: A Feasibility Pilot Study" Journal of Personalized Medicine 16, no. 4: 184.
https://doi.org/10.3390/jpm16040184
APA Style
Chavez-Arias, T., Manrique-Sam, C., Ita-Balta, Y., Montánchez-Carazas, E., Murillo Carrasco, A. G., & Farfán-Delgado, M.
(2026). Population-Specific Pharmacogenomic Profiling of NAT2, CYP2E1, and SLCO1B1 in Tuberculosis Patients from Southern Peru: A Feasibility Pilot Study. Journal of Personalized Medicine, 16(4), 184.
https://doi.org/10.3390/jpm16040184
